scholarly journals Prenatal Cocaine Exposure and Cardiometabolic Disease Risk Factors in 18 to 20 Year Old African Americans

2015 ◽  
Vol 25 (4) ◽  
pp. 419
Author(s):  
Sarah E. Messiah ◽  
David A. Ludwig ◽  
Denise C. Vidot ◽  
Veronica H. Accornero ◽  
Steven E. Lipshultz ◽  
...  
Keyword(s):  
Risk Factors ◽  
Metabolic Disease ◽  
Disease Risk ◽  
Cardiometabolic Disease ◽  
Cocaine Exposure ◽  
Prenatal Cocaine Exposure ◽  
The Metabolic Syndrome ◽  
Prenatal Cocaine ◽  
Cardiometabolic Disease Risk

<p class="Pa7"><strong>Objective: </strong>The long-term effects of prenatal cocaine exposure (PCE) on physical health are largely unknown. No human studies support or refute a relationship between PCE and the long-term risk for cardiovascu­lar and/or metabolic disease. We investi­gated the association of PCE on primary car­diometabolic disease risk factors in African Americans (AA) aged 18 to 20 years.</p><p class="Pa7"><strong>Design: </strong>Cohort, longitudinal, prospective.</p><p class="Pa7"><strong>Setting: </strong>Miami-Dade County, Florida, and the University of Miami Miller School of Medicine/Jackson Memorial Medical Center.</p><p class="Pa7"><strong>Participants: </strong>Healthy full-term inner-city AA adolescents (aged 18 to 20 years, <em>N</em>=350) previously enrolled at birth from 1990-1993.</p><p class="Pa7"><strong>Main Outcome Measures: </strong>Fasting serum insulin, glucose, lipids, and high-sensitivity C-reactive protein; systolic and diastolic blood pressures; and the components and prevalence of the metabolic syndrome.</p><p class="Pa7"><strong>Results: </strong>There were no PCE-associated differences in cardiometabolic disease risk factors including the metabolic syndrome and its individual components in AAs aged 18 to 20 years.</p><p><strong>Conclusions: </strong>The results of our study do not support an association between PCE and increased cardiometabolic disease risk in AAs aged 18 to 20 years. Whether PCE is associated with cardiovascular or metabolic disease in adulthood would require further investigation. <em>Ethn Dis. </em>2015;25(4):419- 426; doi:10.18865/ed.25.4.419</p><strong></strong>

scholarly journals Assessing Latent Effects of Prenatal Cocaine Exposure on Growth and Risk of Cardiometabolic Disease in Late Adolescence: Design and Methods

2012 ◽  
Vol 2012 ◽  
pp. 1-13 ◽  
Author(s):  
Sarah E. Messiah ◽  
Steven E. Lipshultz ◽  
Tracie L. Miller ◽  
Veronica H. Accornero ◽  
Emmalee S. Bandstra
Keyword(s):  
Risk Factors ◽  
Disease Risk ◽  
Late Adolescence ◽  
Cardiometabolic Disease ◽  
Cocaine Exposure ◽  
Prenatal Cocaine Exposure ◽  
Prospective Longitudinal Study ◽  
Prenatal Cocaine ◽  
Prospective Longitudinal ◽  
Cardiometabolic Disease Risk

Prenatal cocaine exposure has been linked to neurocognitive and developmental outcomes throughout childhood. The cardiovascular toxicity of cocaine is also markedly increased in pregnancy, but it is unknown whether this toxicity affects anthropometric growth and the development of cardiometabolic disease risk factors in the offspring across the lifespan. During the early 1990s, the Miami Prenatal Cocaine Study enrolled a cohort of 476 African American children (253 cocaine-exposed, 223 non-cocaine-exposed) and their biological mothers at delivery in a prospective, longitudinal study. The MPCS has collected 12 prior waves of multidomain data on over 400 infants and their mothers/alternate caregivers through mid-adolescence and is now embarking on an additional wave of data collection at ages 18-19 years. We describe here the analytical methods for examining the relationship between prenatal cocaine exposure, anthropometric growth, and cardiometabolic disease risk factors in late adolescence in this minority, urban cohort. Findings from this investigation should inform both the fields of substance use and cardiovascular research about subsequent risks of cocaine ingestion during pregnancy in offspring.

scholarly journals Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors – ERRATUM

2019 ◽  
Vol 49 (10) ◽  
pp. 1758-1758
Author(s):  
Ragni H. Mørch ◽  
Ingrid Dieset ◽  
Ann Færden ◽  
Elina J. Reponen ◽  
Sigrun Hope ◽  
...  
Keyword(s):  
Risk Factors ◽  
Mental Disorders ◽  
Inflammatory Markers ◽  
Disease Risk ◽  
Cardiometabolic Disease ◽  
Severe Mental Disorders ◽  
Cardiometabolic Disease Risk

scholarly journals Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study

Hepatology ◽  
2020 ◽  
Author(s):  
Michelle T. Long ◽  
Xiaoyu Zhang ◽  
Hanfei Xu ◽  
Ching‐Ti Liu ◽  
Kathleen E. Corey ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatic Fibrosis ◽  
Framingham Heart Study ◽  
Disease Risk ◽  
Cardiometabolic Disease ◽  
Heart Study ◽  
Cardiometabolic Disease Risk

Relationship between plasma vitamin D level and cardiometabolic disease risk factors

2012 ◽  
pp. BMP38
Author(s):  
Alaa Badawi ◽  
Bibiana Garcia-Bailo ◽  
Eman Sadoun ◽  
Laura Da Costa ◽  
Paul Arora ◽  
...  
Keyword(s):  
Risk Factors ◽  
Vitamin D ◽  
Disease Risk ◽  
Cardiometabolic Disease ◽  
Plasma Vitamin ◽  
Cardiometabolic Disease Risk

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

2017 ◽  
Vol 8 (6) ◽  
pp. 2076-2088 ◽  
Author(s):  
Arrigo F. G. Cicero ◽  
Federica Fogacci ◽  
Alessandro Colletti
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Cardiovascular Disease Risk Factors ◽  
Cardiometabolic Disease ◽  
Evidence Based ◽  
Cardiometabolic Disease Risk

Nutraceuticals active on the main cardiovascular disease risk factors.

scholarly journals Modeling Sleep and Adiposity-Associated Cardiometabolic Disease Risk Factors: Protocol for the SLUMBRx Study (Preprint)

2021 ◽  
Author(s):  
Adam Knowlden ◽  
John Higginbotham ◽  
Michael Grandner ◽  
John Allegrante
Keyword(s):  
Risk Factors ◽  
Sleep Duration ◽  
Disease Risk ◽  
Cardiometabolic Disease ◽  
Health Issues ◽  
Short Sleep Duration ◽  
Short Sleep ◽  
Adiposity Indices ◽  
The Relationship ◽  
Cardiometabolic Disease Risk

BACKGROUND Obesity and short sleep duration are significant public health issues. Current evidence suggests these conditions are associated with cardiovascular disease, metabolic syndrome, inflammation, and premature mortality. Increased interest in the potential link between obesity and short sleep duration, and its health consequences, has been driven by: 1) the apparent parallel increase in prevalence of both conditions in recent decades; 2) their overlapping association with cardiometabolic outcomes; and 3) the potential causal connection between the two health issues. The Short Sleep Undermines Cardiometabolic Health (SLUMBRx) Study seeks to contribute to the development of a comprehensive adiposity-sleep model, while laying the groundwork for a future program of research that will be designed to prevent and treat adiposity and sleep-related cardiometabolic disease risk factors. OBJECTIVE SLUMBRx addresses four topics pertinent to the adiposity-sleep hypothesis: 1) the relationship between adiposity and sleep duration; 2) sex-based differences in the relationship between adiposity and sleep duration; 3) influence of adiposity indices and sleep duration on cardiometabolic outcomes; and 4) the role of socioecological factors as effect modifiers in the relationship between adiposity indices, sleep, and cardiometabolic outcomes. METHODS SLUMBRx will employ a large-scale survey (n=1,000) that recruits 159 participants (53 normal weight, 53 overweight, and 53 obese) to be assessed in two phases. RESULTS Phase 1, a lab-based study, will gather objective adiposity indices (air displacement plethysmography and anthropometrics) and cardiometabolic data (blood pressure, pulse wave velocity and pulse wave analysis, and blood-based biomarker). Phase 2, a one-week, home-based study, will gather sleep-related data (home sleep testing/sleep apnea, actigraphy, sleep diaries). During Phase 2, detailed demographic and socioecological data will be collected to contextualize hypothesized adiposity and sleep-associated cardiometabolic disease risk factors. Collection and analyses of these data will yield information necessary to customize future observational and intervention research. CONCLUSIONS Precise implementation of the SLUMBRx protocol promises to provide objective, empirical data on the interaction between body composition and sleep duration. The hypotheses that will be tested by SLUMBRx are important for understanding the pathogenesis of cardiometabolic disease and for developing future public health interventions to prevent its conception and treat its consequences. CLINICALTRIAL https://projectreporter.nih.gov/project_info_description.cfm?aid=9822114&icde=45818775

Sign in / Sign up

Export Citation Format

Share Document